| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/20/2005 | CN1607937A Injectable compositions for the controlled delivery of pharmacologically active compound |
| 04/20/2005 | CN1607932A Methods for improving the aesthetic appearance of skin |
| 04/20/2005 | CN1607211A Poly asparaginyl aminoacetic acid, alanine and lysine and its preparation method and medicament purpose |
| 04/20/2005 | CN1607206A Cyclo-glycosyl amino acid, its preparation method and usage in preventing and curing heavy metal poisoning |
| 04/20/2005 | CN1607204A Cyclophosphamide quaternary ammonium salt derivant and its synthesis and use |
| 04/20/2005 | CN1607202A Antibiotic compound, pharmaceutical composition comprising the same and application thereof |
| 04/20/2005 | CN1607010A Antimicrobial adhesive sheet and antimicrobial method using the same |
| 04/20/2005 | CN1607006A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/20/2005 | CN1606983A Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B |
| 04/20/2005 | CN1606982A Fluconazole formulation |
| 04/20/2005 | CN1606981A Use of phentolamine mesylate as therapeutic agent of feminine sterility |
| 04/20/2005 | CN1606980A Novel levamisole formulation for chronic rhinitis |
| 04/20/2005 | CN1606979A Effect of scutellarein as antifebrile, analgesic, antiphlogistic, antibiotic and antiviral agent |
| 04/20/2005 | CN1197972C Process for producing Lycopen |
| 04/20/2005 | CN1197967C Gene sequence of rockfish pituitary rich in reproductive control factor and its use |
| 04/20/2005 | CN1197966C Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 04/20/2005 | CN1197871C 5'-deoxy-cytidine derivatives |
| 04/20/2005 | CN1197869C Aminoglycoside compound having antiviral activity and method for preparing same |
| 04/20/2005 | CN1197867C Application of cinidium general coumarin as psoriasis treating medicine |
| 04/20/2005 | CN1197863C Novel octahydro-2H-pyridino-[1, 2-a] pyrazine compound, its prepn. process and medicinal compound contg. them |
| 04/20/2005 | CN1197861C Method for preparing solid optical pure neutral S- (-) - and (R) - (+) -Omeprazole |
| 04/20/2005 | CN1197860C FAB I inhibitors |
| 04/20/2005 | CN1197859C Febrifugine and isofebrifugine and processes for the preparation of both |
| 04/20/2005 | CN1197854C Lactonization processing method in preparing Tating compounds |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197847C Compound N-total trans dimension methanamide derivative and its preparation method and application |
| 04/20/2005 | CN1197839C Stibene derivative organic amine salt, its preparation method, use and medicinal composition |
| 04/20/2005 | CN1197624C Natural porous polymer beads, the preparation and application thereof |
| 04/20/2005 | CN1197623C Sparagin injection using xylitol as isosmotic adjusting agent |
| 04/20/2005 | CN1197621C Medicinal compositions promoting bowel movement |
| 04/20/2005 | CN1197602C External medicine for treating sterility and women's diseases and its prepn |
| 04/20/2005 | CN1197600C Medicine for curing haemorrhoids |
| 04/20/2005 | CN1197587C Application of position-N desulfurizing heparin in preventing and treating inflammation |
| 04/20/2005 | CN1197586C 原花青素复合物 Proanthocyanidins complex |
| 04/20/2005 | CN1197585C Application of polygonatum polyscaccharide |
| 04/20/2005 | CN1197584C Pourable alginate compositions |
| 04/20/2005 | CN1197583C Ivermectin slow-release injecta, and preparing process and use method thereof |
| 04/20/2005 | CN1197582C Preparation with haw leaf extractive as main effect composition |
| 04/20/2005 | CN1197581C Use of P-benzaldehyde-O-beta-D-allopyranoside for treating depression |
| 04/20/2005 | CN1197580C Medicine containing fritillary total alkali for treating disease of respiratory system and its preparing method |
| 04/20/2005 | CN1197579C Composition for curing bronchial asthma |
| 04/20/2005 | CN1197578C Pharmaceutical suspension comprising nevirapine hemihydrate |
| 04/20/2005 | CN1197577C Therapeutic use of 4-anilino quinazoline derivative in preparing drug for preventing breast cancer paroxysm |
| 04/20/2005 | CN1197576C Medicine for treating venereal wart and its preparation method |
| 04/20/2005 | CN1197575C Cetirizing hydrochloride cataplasm preparation |
| 04/20/2005 | CN1197574C Method for stabilizing benzimidazole compounds |
| 04/20/2005 | CN1197573C Liniment of levamisole hydrochloride |
| 04/20/2005 | CN1197572C Hypoalbuminemia improvement agent |
| 04/20/2005 | CN1197571C Metronidazole preparation and its preparing method |
| 04/20/2005 | CN1197570C Application of ampelopsin in preparation of medicine for preventing and treating AIDS |
| 04/20/2005 | CN1197569C New treatments for neuropathy |
| 04/20/2005 | CN1197568C Dihydroarteannuin preparation for controlling broad-spectrum malaria and its preparation method |
| 04/20/2005 | CN1197567C Application of kaempferol derivative in preparing medicine for cerebrovascular diseases |
| 04/20/2005 | CN1197566C Ophthalmic fluid |
| 04/20/2005 | CN1197565C Method for preventing or delaying catheter-based revascularization |
| 04/20/2005 | CN1197564C Application of fur seal oil in preparation of medicine for treating lipometabolism disorder |
| 04/20/2005 | CN1197563C Compound composition for curing male's sterility |
| 04/20/2005 | CN1197562C Application of sodium ferulate in preparing medicine to prevent and cure heptofibrosis |
| 04/20/2005 | CN1197561C Application of calcium L-threonate in preparing drug of preventing or treating cartilage related diseases |
| 04/20/2005 | CN1197560C Medicine for preventing or treating AIDS, and preparation and application thereof |
| 04/20/2005 | CN1197557C Constant speed release terbutaline controlled releasing preparation |
| 04/20/2005 | CN1197554C Solid lipid formulations |
| 04/20/2005 | CN1197553C Method of producing vitamin powder |
| 04/20/2005 | CN1197552C Preparations for the application of anti-inflammatory agents |
| 04/20/2005 | CN1197551C Dispersion formulations containing lipase inhibitors |
| 04/20/2005 | CN1197550C Composition set and kit for use in intraocular surgery |
| 04/20/2005 | CN1197541C Two chamber cartridge for atomizers |
| 04/20/2005 | CN1197483C Method of producing oily suspensions of water-soluble vitamins |
| 04/20/2005 | CN1197481C Method for treatment of chronic venous functionalinsufficiencies using extract of red vine leaves |
| 04/20/2005 | CN1197476C Fodder additive for resisting silkworm microsporidian |
| 04/19/2005 | US6881860 Compounds and methods to increase plasma HDL cholesterol levels and improve HDL functionality |
| 04/19/2005 | US6881857 Tricyclic diterpene derivatives |
| 04/19/2005 | US6881854 Conjugated unsaturated glyceride mixtures and a method for producing the same |
| 04/19/2005 | US6881841 Dibenzosuberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| 04/19/2005 | US6881831 Treating against hepatitis infections, particularly hepatitis B viral infections. Compounds of the invention are nucleic acid-based and preferably comprise 2, 3, 4, 5 or 6 nucleoside units. |
| 04/19/2005 | US6881822 Antibody for use in the treatment of tumors |
| 04/19/2005 | US6881789 A biopolymer containing a mixture of ubiquitin and at least one cross-linking agent which is selected from photoreactive or thermoreactive crosslinker |
| 04/19/2005 | US6881776 Two-phase gel compositions obtained by mixing a gelled ester, ether, alcohol, natural fats or oils, triblock copolymers, star polymers, radial polymers, multi-block copolymers; and a hydrophobic, nonpolar solvent. |
| 04/19/2005 | US6881756 Method for treating skin disorders |
| 04/19/2005 | US6881755 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 04/19/2005 | US6881754 Adamantane derivatives |
| 04/19/2005 | US6881753 Potassium channel inhibitors and method |
| 04/19/2005 | US6881752 (Cr3O(O2CCH2CH3)6(H2O)3)+ used in conjuction with insulin as an antidiabetic agents as well as for cardiovascular disorders; activates insulin-dependent tyrosine protein kinase activity of insulin receptor approximately eightfold |
| 04/19/2005 | US6881751 Medicament containing platinum complex compounds and the use thereof |
| 04/19/2005 | US6881750 Potassium taurate bicarbonate and ascorbate |
| 04/19/2005 | US6881749 Pyranoindazoles and their use for the treatment of glaucoma |
| 04/19/2005 | US6881748 Drug targeting |
| 04/19/2005 | US6881746 Hypoglycemic agents; antidiabetic agents |
| 04/19/2005 | US6881745 Pharmaceutical compositions for poorly soluble drugs |
| 04/19/2005 | US6881744 Carbinoxamine tannate |
| 04/19/2005 | US6881743 Pyridine matrix metalloproteinase inhibitors |
| 04/19/2005 | US6881742 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 04/19/2005 | US6881741 Such as 3-(4-Chloro-2,5-dimethyl-benzenesulfonylamino)-5-(4-chloro-phenyl)-thiophene-2-carboxylic acid; for treatment of hepatitis |
| 04/19/2005 | US6881740 Pharmaceutical agents |
| 04/19/2005 | US6881739 Use of cortisol antagonists in the treatment of heart failure |
| 04/19/2005 | US6881736 Inhibit the vitronectin receptor and are useful for the treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881734 Pharmaceutical composition for the treatment of CNS and other disorders |
| 04/19/2005 | US6881733 Serotonergic benzofurans |